ANTX icon

AN2 Therapeutics

36 hedge funds and large institutions have $72.4M invested in AN2 Therapeutics in 2022 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$1.45M
2 +$1.03M
3 +$834K
4
Citigroup
Citigroup
New York
+$680K
5
RCM
RA Capital Management
Massachusetts
+$633K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$29.1M
2
$12.5M
3
$9.92M
4
$5.55M
5
$5.33M
6
$1.81M
7
$1.45M
8
$1.41M
9
$969K
10
$832K
11
$680K
12
$592K
13
$375K
14
$350K
15
$313K
16
$282K
17
$209K
18
$199K
19
$165K
20
$88K
21
$79K
22
$48K
23
$38K
24
$34K
25
$19K